{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:48:48Z","timestamp":1763563728459},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2161,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1111\/j.1365-2230.2009.03475.x","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T08:59:12Z","timestamp":1248857952000},"page":"757-760","source":"Crossref","is-referenced-by-count":24,"title":["Extracorporeal photopheresis: what is it and when should it be used?"],"prefix":"10.1093","volume":"34","author":[{"given":"J.","family":"Scarisbrick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198702053160603","article-title":"Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary results","volume":"316","author":"Edelson","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2133.2007.08415.x","article-title":"UK consensus statement on the use of extra-corporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft versus host disease","volume":"158","author":"Scarisbrick","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB3","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0190-9622(96)90119-X","article-title":"Treatment of CTCL with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution","volume":"35","author":"Gottlieb","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0781.1999.tb00077.x","article-title":"Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience","volume":"15","author":"Jiang","year":"1999","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB5","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-2133.2003.05698.x","article-title":"Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas","volume":"149","author":"Whittaker","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2133.2005.06857.x","article-title":"Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group","volume":"154","author":"McKenna","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB7","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ejca.2006.01.025","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/Sezary syndrome","volume":"42","author":"Trautinger","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1067\/mjd.2001.110645","article-title":"Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial","volume":"44","author":"Wollina","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/12034754030070S402","article-title":"Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma","volume":"7","author":"Duvic","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/archderm.138.8.1054","article-title":"Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution","volume":"138","author":"Suchin","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB11","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1182\/blood.V92.9.3098","article-title":"Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease","volume":"92","author":"Greinix","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/sj.bmt.1704984","article-title":"Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors","volume":"35","author":"Foss","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB13","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2008-03-141481","article-title":"A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease","volume":"112","author":"Flowers","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB14","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1182\/blood.V96.7.2426","article-title":"Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study","volume":"96","author":"Greinix","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/bmt.2008.221","article-title":"Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD","volume":"42","author":"Perfetti","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB16","first-page":"405","article-title":"The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease","volume":"91","author":"Greinix","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.transproceed.2008.03.071","article-title":"Potential applications of extracorporeal photopheresis in liver transplantation","volume":"40","author":"Urbani","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1034\/j.1600-0781.2002.02762.x","article-title":"Extracorporeal photochemotherapy - The Columbia Presbyterian experience","volume":"18","author":"Knobler","year":"2002","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB19","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1751-1097.1979.tb07838.x","article-title":"Photochemistry and photobiology of psoralens","volume":"29","author":"Song","year":"1979","journal-title":"Photochem Photobiol"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB20","first-page":"1","article-title":"Extracorporeal photochemotherapy","volume":"4","author":"Edelson","year":"1994","journal-title":"Biol Ther Cancer Updates"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/1523-1747.ep12499907","article-title":"Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha in monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis","volume":"98","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB22","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1525-1594.1994.tb03340.x","article-title":"Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma autoimmune disease and allograft rejection","volume":"18","author":"Wolfe","year":"1994","journal-title":"Artif Organs"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000246076","article-title":"Extracorporeal photochemotherapy induces a significant increase in CD36+ circulating monocytes in patients with mycosis fungoides","volume":"194","author":"Fimiani","year":"1997","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1172\/JCI1112","article-title":"Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta PGE2 and PAF","volume":"101","author":"Fadok","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1073>3.0.CO;2-R","article-title":"Induction of tumor loaded dendritic cells","volume":"91","author":"Berger","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.med.50.1.507","article-title":"Dendritic cell vaccines for cancer immunotherapy","volume":"50","author":"Timmerman","year":"1999","journal-title":"Annu Rev Med"},{"key":"10.1111\/j.1365-2230.2009.03475.x-BIB28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ncponc0511","article-title":"Technology insight. ECP for the treatment of GvHD - can we offer selective immune control without generalized immunosuppression?","volume":"3","author":"Marshall","year":"2006","journal-title":"Nat Clin Pract Oncol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2009.03475.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2009.03475.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:30:08Z","timestamp":1676385008000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/34\/7\/757\/6625052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03475.x","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}